Cargando…
The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT)
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565089/ http://dx.doi.org/10.1186/2050-6511-16-S1-A58 |
| _version_ | 1782389553981554688 |
|---|---|
| author | Huntgeburth, Michael Kießling, Johannes Weimann, Gerrit Kiepsel, Verena Saleh, Soundos Hunzelmann, Nicolas Rosenkranz, Stephan |
| author_facet | Huntgeburth, Michael Kießling, Johannes Weimann, Gerrit Kiepsel, Verena Saleh, Soundos Hunzelmann, Nicolas Rosenkranz, Stephan |
| author_sort | Huntgeburth, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4565089 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45650892015-09-18 The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT) Huntgeburth, Michael Kießling, Johannes Weimann, Gerrit Kiepsel, Verena Saleh, Soundos Hunzelmann, Nicolas Rosenkranz, Stephan BMC Pharmacol Toxicol Meeting Abstract BioMed Central 2015-09-02 /pmc/articles/PMC4565089/ http://dx.doi.org/10.1186/2050-6511-16-S1-A58 Text en Copyright © 2015 Huntgeburth et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Meeting Abstract Huntgeburth, Michael Kießling, Johannes Weimann, Gerrit Kiepsel, Verena Saleh, Soundos Hunzelmann, Nicolas Rosenkranz, Stephan The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT) |
| title | The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT) |
| title_full | The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT) |
| title_fullStr | The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT) |
| title_full_unstemmed | The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT) |
| title_short | The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT) |
| title_sort | sgc-stimulator riociguat for the treatment of raynaud's phenomenon: a single-dose, double-blind, randomized, placebo-controlled cross-over study (digit) |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565089/ http://dx.doi.org/10.1186/2050-6511-16-S1-A58 |
| work_keys_str_mv | AT huntgeburthmichael thesgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT kießlingjohannes thesgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT weimanngerrit thesgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT kiepselverena thesgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT salehsoundos thesgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT hunzelmannnicolas thesgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT rosenkranzstephan thesgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT huntgeburthmichael sgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT kießlingjohannes sgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT weimanngerrit sgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT kiepselverena sgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT salehsoundos sgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT hunzelmannnicolas sgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit AT rosenkranzstephan sgcstimulatorriociguatforthetreatmentofraynaudsphenomenonasingledosedoubleblindrandomizedplacebocontrolledcrossoverstudydigit |